Given the proposed acquisition of Shockwave Medical by Johnson & Johnson, Shockwave Medical is withdrawing its full year 2024 guidance, previously issued on February 15, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
330.1 USD | -0.23% | -0.13% | +73.24% |
05-16 | Johnson & Johnson to Buy Proteologix For $850 Million in Cash | MT |
05-13 | Johnson & Johnson Offering Notes to Help Fund Shockwave Medical Acquisition | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+73.24% | 12.39B | |
-19.09% | 7.89B | |
+13.24% | 5.43B | |
+38.48% | 4.96B | |
-17.30% | 4.72B | |
-19.78% | 4.02B | |
-29.53% | 2.66B | |
+47.29% | 2.37B | |
-2.10% | 1.96B | |
+6.56% | 1.92B |
- Stock Market
- Equities
- SWAV Stock
- News Shockwave Medical, Inc.
- Shockwave Medical Withdraws Earnings Guidance for the Full Year 2024